Your browser doesn't support javascript.
loading
Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's Perspective.
Qu, Tingting; Zhang, Shujing; Zhong, Yichen; Meng, Yang; Guo, He; Joo, Seongjung; Enzinger, Peter C.
Afiliación
  • Qu T; Health Economics and Analysis, Lumanity, Bethesda, MD, USA.
  • Zhang S; Departments of Biostatistics and Research Decision Sciences/Health Economic and Decision Sciences, Merck & Co., Inc., Rahway, NJ, USA. shujing.zhang@merck.com.
  • Zhong Y; Departments of Biostatistics and Research Decision Sciences/Health Economic and Decision Sciences, Merck & Co., Inc., Rahway, NJ, USA.
  • Meng Y; Health Economics and Analysis, Lumanity, Bethesda, MD, USA.
  • Guo H; Departments of Biostatistics and Research Decision Sciences/Health Economic and Decision Sciences, Merck & Co., Inc., Rahway, NJ, USA.
  • Joo S; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, USA.
  • Enzinger PC; Dana-Farber Cancer Institute, Harvard University, Boston, MA, USA.
Pharmacoeconomics ; 40(12): 1247-1259, 2022 12.
Article en En | MEDLINE | ID: mdl-36241842
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Platino (Metal) / Neoplasias Esofágicas Tipo de estudio: Evaluation_studies / Health_economic_evaluation Idioma: En Revista: Pharmacoeconomics Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Platino (Metal) / Neoplasias Esofágicas Tipo de estudio: Evaluation_studies / Health_economic_evaluation Idioma: En Revista: Pharmacoeconomics Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article